Randomized trial of liposomal bupivacaine for hip fracture surgery Liposomal bupivacaine is a long-acting local anesthetic developed for use in relieving postoperative pain, allowing drug release ...

Liposomal bupivacaine is a formulation of local anesthetic which has the potential to provide anesthesia for up to 72 hours following administration. The purpose of this study was to compare the ...

Randomized trial of liposomal bupivacaine for hip fracture surgery Liposomal bupivacaine is a long-acting local anesthetic ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today ...

About Pacira Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL ® (bupivacaine liposome ...

In the final rule, CMS confirmed that both EXPAREL® (bupivacaine liposome injectable suspension) and iovera° qualify as eligible non-opioid pain management products under the NOPAIN Act.